# AEVEX Corp.: overview

AVEX · NYSE · CIK 2096300 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/avex.md) · [Financials](/companies/avex/financials.md) · [Filings](/companies/avex/filings.md) · [Insiders](/companies/avex/insiders.md)

Latest reported revenue: [$201.8m](/filings/0002096300-26-000022.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 12, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0002096300-26-000022).

## Last eight quarters

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | [101](/filings/0002096300-26-000022.md) | not reported | [202](/filings/0002096300-26-000022.md) |
| Gross margin | % | not reported | [18.2%](/filings/0002096300-26-000022.md) | not reported | [23.6%](/filings/0002096300-26-000022.md) |
| Operating margin | % | not reported | [(3.5%)](/filings/0002096300-26-000022.md) | not reported | [7.6%](/filings/0002096300-26-000022.md) |
| Net margin | % | not reported | [(11.7%)](/filings/0002096300-26-000022.md) | not reported | [1.2%](/filings/0002096300-26-000022.md) |
| Diluted EPS | $ per share | not reported | [0.00](/filings/0002096300-26-000022.md) | not reported | [0.01](/filings/0002096300-26-000022.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL not reported.

## Last five fiscal years

Not reported.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/avex/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Fidelity National Financial, Inc.](/funds/1331875.md) | 2026-06-30 | $124.0m | 5,937,500 |  | New +5,937,500 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $72.0m | 3,447,774 |  | New +3,447,774 |
| [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $45.3m | 2,169,293 |  | New +2,169,293 |
| [PRINCIPAL FINANCIAL GROUP INC](/funds/1126328.md) | 2026-06-30 | $35.9m | 1,718,681 |  | New +1,718,681 |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $30.2m | 1,445,032 |  | New +1,445,032 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $24.6m | 1,369,363 |  | New +1,369,363 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $23.4m | 1,119,755 |  | New +1,119,755 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $21.7m | 1,040,071 |  | New +1,040,071 |
| [Alyeska Investment Group, L.P.](/funds/1453072.md) | 2026-06-30 | $19.9m | 952,774 |  | New +952,774 |
| [MASSACHUSETTS FINANCIAL SERVICES CO /MA/](/funds/912938.md) | 2026-06-30 | $12.3m | 588,253 |  | New +588,253 |

## Recent filings

[All 61 filings](/companies/avex/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-08 | 16:43 ET | [8-K](/filings/0001193125-26-385301.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-385301 |
| 2026-08-12 | 16:18 ET | [8-K](/filings/0001193125-26-346904.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-346904 |
| 2026-08-12 | 16:15 ET | [10-Q](/filings/0002096300-26-000022.md) | Quarterly report, period 2026-06-30 | 0002096300-26-000022 |
| 2026-08-12 | 16:15 ET | [8-K](/filings/0002096300-26-000023.md) | 9.01 Financial statements and exhibits | 0002096300-26-000023 |
| 2026-06-05 | 16:20 ET | [8-K](/filings/0001193125-26-259643.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-259643 |
| 2026-06-01 | 16:35 ET | [S-1](/filings/0001193125-26-251569.md) | Registration statement | 0001193125-26-251569 |
| 2026-05-20 | 16:15 ET | [10-Q](/filings/0002096300-26-000012.md) | Quarterly report, period 2026-03-31 | 0002096300-26-000012 |
| 2026-05-20 | 16:11 ET | [8-K](/filings/0002096300-26-000011.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002096300-26-000011 |
| 2026-04-24 | 16:15 ET | [8-K](/filings/0001193125-26-177298.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-177298 |
| 2026-04-20 | 17:00 ET | [8-K](/filings/0001193125-26-164202.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-164202 |

## Latest annual report

No annual report is in coverage.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/2c5fdf42-9a4c-479e-9764-d64473a885cd)

## About the filer

- CIK: 2096300
- Tickers: AVEX
- Exchange: NYSE
- SIC code: 3721 Aircraft
- State of incorporation: DE
- Filer category: <br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 09:52 ET. No prices; not investment advice.
